The blood compatibility of ventricular assist devices developed by the Helmholtz institute Aachen (HA-VAD's) was tested on calves. Seven calves received a non-coated HIA-VAD (control) and three a Bioline heparin coated device. The circulatory support of these HIA-VAD's lasted one week. Mechanical blood cell trauma estimated by hematocrit (Hot), hemoglobin (total Nb) and free plasma hemoglobin (free Hb) levels did not differ in either group. All HIA-VAD's in the control group remained thrombus free, except on one occasion when an inflow cannula was obstructed by a thrombus located in the tip. After circulatory support, the animals in this group seemed clinically healthy However, thrombus formation was observed in the three heparin coated HIA...
Coating of cardiopulmonary bypass circuits may be a solution to prevent adverse effects induced by c...
Abstract: To treat acute lung failure, an intravenous membrane gas exchange device, the Hattler Cath...
The thrombogenicity of membrane oxygenators as well as clotting parameters profiles, using standard ...
The blood compatibility of ventricular assist devices developed by the Helmholtz institute Aachen (H...
Heparin surface coated ventricular assist devices (VADs) and cannulas were evaluated in comparison t...
Heparin surface coated ventricular assist devices (VADs) were evaluated without systemic heparinizat...
Helmholtz Ventricular Assist Devices (VAD) are pneumatically driven polyurethane membrane pumps with...
Heart failure results in significant morbidity and mortality for those afflicted. The current gold s...
Objective: To assess the hemocompatible performance of a novel implantable pneumatic ventricular ass...
Helmholtz Ventricular Assist Devices (VAD) are pneumatically driven polyurethane membrane pumps with...
Bleeding and thromboembolism remain major complications of ventricular assist device (VAD) support. ...
A number of heart assist devices including the PediaFlowTM ventricular assist device (VAD), a magnet...
Heparin surface coating is one approach to improve the biocompatibility of existing blood pumps used...
Cardiopulmonary bypass (n = 8 calves) with heparin-coated perfusion equipment, low-dose systemic hep...
The common complications in heart failure patients with implanted ventricular assist devices (VADs) ...
Coating of cardiopulmonary bypass circuits may be a solution to prevent adverse effects induced by c...
Abstract: To treat acute lung failure, an intravenous membrane gas exchange device, the Hattler Cath...
The thrombogenicity of membrane oxygenators as well as clotting parameters profiles, using standard ...
The blood compatibility of ventricular assist devices developed by the Helmholtz institute Aachen (H...
Heparin surface coated ventricular assist devices (VADs) and cannulas were evaluated in comparison t...
Heparin surface coated ventricular assist devices (VADs) were evaluated without systemic heparinizat...
Helmholtz Ventricular Assist Devices (VAD) are pneumatically driven polyurethane membrane pumps with...
Heart failure results in significant morbidity and mortality for those afflicted. The current gold s...
Objective: To assess the hemocompatible performance of a novel implantable pneumatic ventricular ass...
Helmholtz Ventricular Assist Devices (VAD) are pneumatically driven polyurethane membrane pumps with...
Bleeding and thromboembolism remain major complications of ventricular assist device (VAD) support. ...
A number of heart assist devices including the PediaFlowTM ventricular assist device (VAD), a magnet...
Heparin surface coating is one approach to improve the biocompatibility of existing blood pumps used...
Cardiopulmonary bypass (n = 8 calves) with heparin-coated perfusion equipment, low-dose systemic hep...
The common complications in heart failure patients with implanted ventricular assist devices (VADs) ...
Coating of cardiopulmonary bypass circuits may be a solution to prevent adverse effects induced by c...
Abstract: To treat acute lung failure, an intravenous membrane gas exchange device, the Hattler Cath...
The thrombogenicity of membrane oxygenators as well as clotting parameters profiles, using standard ...